Mortality among antiretroviral-eligible patients in an urban public clinic

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 4, 2011, Pages 297-300

  Dowdy, David W ^a   Geng, Elvin H ^b   Christopoulos, Katerina A ^b   Kahn, James S ^b   Hare, C Bradley ^b   Wlodarczyk, Daniel ^b   Havlir, Diane V ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

delivery of health care; HIV; mortality; urban health

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DRUG USE; FEMALE; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HOSPITAL; TREND STUDY; UNITED STATES; URBAN POPULATION; VIOLENCE; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; OVERDOSE; RISK FACTORS; SAN FRANCISCO; STREET DRUGS; TIME FACTORS; VIOLENCE; VIRAL LOAD;

EID: 79959985872     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31822233aa     Document Type: Article

References (14)

1. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010;376:49-62.
2. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299.
3. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50: 1387-1396.
4. Study group on death rates at high CD4 count in antiretroviral naive patients. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet. 2010;376:340-345.
5. Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York city. Ann Intern Med. 2006;145:397-406. (Pubitemid 46768570)
6. Kitahata MM, Rodriguez B, Haubrich R, et al. Cohort profile: the centers for AIDS research network of integrated clinical systems. Int J Epidemiol. 2008;37:948-955.
7. Moss AR, Hahn JA, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004;39:1190-1198. (Pubitemid 40169319)
8. Kushel MB, Hahn JA, Evans JL, et al. Revolving doors: imprisonment among the homeless and marginally housed population. Am J Public Health. 2005;95:1747-1752. (Pubitemid 41369044)
9. Weiser SD, Fernandes KA, Brandson EK, et al.The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr. 2009;52:342-349.
10. Kimber J, Copeland L, Hickman M, et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ. 2010;341:c3172.
11. Kushel MB, Colfax G, Ragland K, et al. Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis. 2006;43:234-242.
12. Altice FL, Kamarulzaman A, Soriano VV, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376:367-387.
13. Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Washington, DC: The White House, July 13, 2010. Available at: http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf. Accessed January 18, 2011.
14. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5:e11068.